Logo.png
Foresight and Tata Elxsi Sign Collaboration Agreement
October 25, 2024 08:21 ET | Foresight Autonomous Holdings Ltd.
The parties will collaborate to accelerate development of solutions for semi-autonomous and autonomous vehicles using Foresight’s stereoscopic technology and Tata Elxsi’s integration solutions for...
purple-logo2020.png
Purple Biotech Presents New Data for its Novel Tri-Specific T Cell and NK Cell Engagers Antibody Platform, CAPTN-3, at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
October 25, 2024 07:20 ET | Purple Biotech Ltd.
CAPTN-3 demonstrates sustained tumor regression in a triple negative breast cancer in-vivo model; A dose dependent activity and a synergistic effect of the engager arms also seen in non-small cell...
Asset 9@3x.png
Nayax to Report 2024 Q3 Earnings on November 12, 2024
October 22, 2024 16:37 ET | Nayax Ltd.
HERZLIYA, Israel, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), a global commerce enablement, payments and loyalty platform designed to help merchants scale their...
PGAIS Improvement Rate
Dr. Kavita Darji Wins the Drs. Alastair and Jean D. Carruthers Award at ASDS 2024 for Sofwave SUPERB™ Abstract
October 22, 2024 08:45 ET | SofWave Medical, Ltd.
SAN CLEMENTE, Calif., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced...
teva_RGB_JPEG.jpg
Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of SELARSDI™ (ustekinumab-aekn), Expanding its Label to Include Further Indications Approved for Reference Product, Stelara® (ustekinumab)
October 22, 2024 07:00 ET | Teva Pharmaceutical Industries Ltd
Approval of SELARSDI 130 mg/26 mL in a single-dose vial for intravenous infusion expands label to include treatment of adults with Crohn’s disease and ulcerative colitisThe FDA previously approved...
Gilat Logo Full Color.png
Gilat Satellite Networks to Attend APEX/IFSA Conference to Discuss State-of the Art In-Flight Connectivity Solutions for Aviation Markets
October 22, 2024 05:05 ET | Gilat Satellite Networks Ltd.
PETAH TIKVA, Israel, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services,...
Tower-logo-CMYKtag.png
Tower Semiconductor Announces Third Quarter 2024 Financial Results and Conference Call
October 21, 2024 06:00 ET | Tower Semiconductor
MIGDAL HAEMEK, Israel – October 21, 2024 – Tower Semiconductor (NASDAQ/ TASE: TSEM), the leading foundry of high-value analog semiconductor solutions, will issue its third quarter 2024 earnings...
Gilat Logo Full Color.png
Gilat to Report Third Quarter 2024 Results on Wednesday, November 13th
October 21, 2024 05:03 ET | Gilat Satellite Networks Ltd.
PETAH TIKVA, Israel, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, today...
Can-Fite BioPharma Logo.jpg
Significant Positive Results from Osteoarthritis Clinical Study in Dogs Treated with Piclidenoson
October 18, 2024 09:06 ET | Can-Fite BioPharma Ltd.
Data Reported by Can-Fite Veterinary Partner Vetbiolix who already exercised its option for a full license deal worth $325M Ramat Gan, Israel, Oct. 18, 2024 (GLOBE NEWSWIRE) --...
Gilat Logo Full Color.png
Gilat Satellite Networks to Present at the 17th Annual LD Micro Invitational Conference
October 16, 2024 06:00 ET | Gilat Satellite Networks Ltd.
PETAH TIKVA, Israel, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, announced...